PCM
Penserra Capital Management Portfolio holdings
AUM
$7.17B
1-Year Return
49.58%
This Quarter Return
+33.7%
1 Year Return
+49.58%
3 Year Return
+118.16%
5 Year Return
+229.83%
10 Year Return
–
AUM
$4.23B
AUM Growth
+$1.6B
(+61%)
Cap. Flow
+$935M
Cap. Flow
% of AUM
22.08%
Top 10 Holdings %
Top 10 Hldgs %
21.32%
Holding
1,174
New
230
Increased
606
Reduced
167
Closed
168
Top Buys
| 1 |
KE Holdings
BEKE
|
+$78.6M |
| 2 |
Lufax Holding
LU
|
+$56.6M |
| 3 |
Groupon
GRPN
|
+$50.3M |
| 4 |
JD.com
JD
|
+$43.7M |
| 5 |
Lands' End
LE
|
+$36.7M |
Top Sells
| 1 |
JMIA
Jumia Technologies
JMIA
|
+$35.9M |
| 2 |
Peloton Interactive
PTON
|
+$31.3M |
| 3 |
Match Group
MTCH
|
+$23.5M |
| 4 |
Fiverr
FVRR
|
+$16.6M |
| 5 |
Stitch Fix
SFIX
|
+$14.7M |
Sector Composition
| 1 | Consumer Discretionary | 35.59% |
| 2 | Technology | 23.48% |
| 3 | Communication Services | 13.86% |
| 4 | Real Estate | 4.37% |
| 5 | Industrials | 4.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Henry Schein
HSIC
$8.17B
| $19K | ﹤0.01% |
299
+61
| +26% | +$3.88K |
|
852
LKQ Corp
LKQ
$8.26B
| $19K | ﹤0.01% |
551
-2,268
| -80% | -$78.2K |
|
853
Lincoln National
LNC
$7.88B
| $19K | ﹤0.01% |
385
+45
| +13% | +$2.22K |
|
854
Sutro Biopharma
STRO
$77.2M
| $19K | ﹤0.01% |
+900
| New | +$19K |
|
855
W.R. Berkley
WRB
$27.4B
| $19K | ﹤0.01% |
646
+187
| +41% | +$5.5K |
|
|
RDUS
856
DELISTED
Radius Health, Inc.
RDUS
| $19K | ﹤0.01% |
1,085
+689
| +174% | +$12.1K |
|
857
LendingClub
LC
$1.86B
| $18K | ﹤0.01% |
1,706
-1,691
| -50% | -$17.8K |
|
858
Pliant Therapeutics
PLRX
$104M
| $18K | ﹤0.01% |
+825
| New | +$18K |
|
859
Quince Therapeutics
QNCX
$86.5M
| $18K | ﹤0.01% |
+675
| New | +$18K |
|
860
Western Union
WU
$2.73B
| $18K | ﹤0.01% |
865
-3,487
| -80% | -$72.6K |
|
|
ICPT
861
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $18K | ﹤0.01% |
765
+483
| +171% | +$11.4K |
|
|
Y
862
DELISTED
Alleghany Corporation
Y
| $18K | ﹤0.01% |
30
-4
| -12% | -$2.4K |
|
|
FPRX
863
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $18K | ﹤0.01% |
+1,065
| New | +$18K |
|
|
PRVL
864
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $18K | ﹤0.01% |
785
+493
| +169% | +$11.3K |
|
|
ADAP
865
Adaptimmune Therapeutics
ADAP
$13.5M
| $17K | ﹤0.01% |
+3,180
| New | +$17K |
|
866
First Solar
FSLR
$21.9B
| $17K | ﹤0.01% |
179
-888
| -83% | -$84.3K |
|
867
Iron Mountain
IRM
$28.8B
| $17K | ﹤0.01% |
604
+128
| +27% | +$3.6K |
|
868
Omega Healthcare
OHI
$12.6B
| $17K | ﹤0.01% |
478
+104
| +28% | +$3.7K |
|
869
Protagonist Therapeutics
PTGX
$3.59B
| $17K | ﹤0.01% |
880
+564
| +178% | +$10.9K |
|
|
VER
870
DELISTED
VEREIT, Inc.
VER
| $17K | ﹤0.01% |
454
+94
| +26% | +$3.52K |
|
871
Comerica
CMA
$8.9B
| $16K | ﹤0.01% |
290
+52
| +22% | +$2.87K |
|
872
Esperion Therapeutics
ESPR
$524M
| $16K | ﹤0.01% |
640
+404
| +171% | +$10.1K |
|
873
Gossamer Bio
GOSS
$707M
| $16K | ﹤0.01% |
1,755
+1,107
| +171% | +$10.1K |
|
|
IMAB
874
I-MAB
IMAB
$341M
| $16K | ﹤0.01% |
+360
| New | +$16K |
|
875
MannKind Corp
MNKD
$1.71B
| $16K | ﹤0.01% |
5,335
+3,381
| +173% | +$10.1K |
|